{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:20:01Z","timestamp":1790706001130,"version":"4.1.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejmech.2018.11.032","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T02:45:19Z","timestamp":1541990719000},"page":"396-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"special_numbering":"C","title":["Fluoroquinolone-isatin hybrids and their biological activities"],"prefix":"10.1016","volume":"162","author":[{"given":"Zhi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zao-Sheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Lun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.11.032_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram positive pathogens","volume":"144","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their anti-bacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib4","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/15680266113139990133","article-title":"Insight view on possible role of fluoroquinolones in cancer therapy","volume":"13","author":"Sharma","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cclet.2016.07.024","article-title":"Synthesis and in\u00a0vitro antitumor activity of novel naphthyridinone derivatives","volume":"28","author":"Jia","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.11.032_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone derivatives and their anti-tubercular activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2018.01.039","article-title":"Antiplasmodial and antimalarial activities of quinolone derivatives: an overview","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2017.07.061","article-title":"Quinoline hybrids and their antiplasmodial and antimalarial activities","volume":"139","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.2174\/1389557511009011046","article-title":"Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview","volume":"10","author":"Luo","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib10","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bioorg.2017.09.015","article-title":"Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N-Cycloalkylbenzamido)methyl]-2-Quinolones as potential HIV-1 integrase inhibitors","volume":"75","author":"Sekgota","year":"2017","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bmcl.2017.11.047","article-title":"Synthesis, in\u00a0vitro \u03b1-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib12","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1016\/j.bmcl.2017.07.069","article-title":"Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: design, synthesis, biological investigation and docking studies","volume":"27","author":"Singh","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"2","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.11.032_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/1389557517666161111110121","volume":"17","author":"Matias","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib15","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/17460440902956636","volume":"4","author":"Francis","year":"2009","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.032_bib17","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/jhet.3234","article-title":"Quinolone-triazole hybrids and their biological activities","volume":"55","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1568026618666180221114515","article-title":"Bis-coumarin derivatives and their biological activities","volume":"18","author":"Ren","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib19","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/jhet.3244","article-title":"4-Quinolone derivatives and their activities against Gram-negative pathogens","volume":"55","author":"Jiang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib20","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their anti-bacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib22","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/slct.201703051","article-title":"Molecular design, synthesis, computational screening, antimicrobial evaluation and molecular docking study of acetylinic isatin hybrids","volume":"3","author":"Singh","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2018.11.032_bib23","first-page":"280","article-title":"Synthesis and anti-bacterial activity of Mannich bases of ciprofloxacin and lomefloxacin with isatin and its derivative","volume":"60","author":"Pandeya","year":"1998","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.11.032_bib24","first-page":"103","article-title":"Synthesis, anti-bacterial, antifungal and anti-HIV evaluation of norfloxacin Mannich bases","volume":"67","author":"Pandeya","year":"1999","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.ejmech.2018.11.032_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0223-5234(00)00125-2","article-title":"Synthesis, anti-bacterial, antifungal and anti-HIV activities of norfloxacin Mannich bases","volume":"35","author":"Pandeya","year":"2000","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00044-005-0135-x","article-title":"Synthesis, antiviral and anti-bacterial activities of isatin Mannich bases","volume":"14","author":"Sriram","year":"2005","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.11.032_bib27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.farmac.2005.03.005","article-title":"Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation","volume":"60","author":"Sriram","year":"2005","journal-title":"IL Farmaco"},{"key":"10.1016\/j.ejmech.2018.11.032_bib28","first-page":"337","article-title":"Synthesis, characterization and in\u00a0vitro antimicrobial activity of some novel 5-substituted Schiff and Mannich base of isatin derivatives","volume":"17","author":"Prakash","year":"2013","journal-title":"J.\u00a0Saudi Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.11.032_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","article-title":"Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib30","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/jhet.3226","article-title":"Design, synthesis, and in\u00a0vitro anti-bacterial activities of propylenetethered gatifloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib31","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/jhet.3279","article-title":"Design, synthesis, and anti-bacterial evaluation of propylene-tethered 8-methoxyl ciprofloxacin-isatin hybrids","volume":"55","author":"Guo","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib32","first-page":"5377","article-title":"Synthesis and anti-bacterial activity of N-norfloxacin Mannich bases of isatin and its derivatives","volume":"20","author":"Pandeya","year":"2008","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib33","first-page":"1","volume":"2018","year":"2018"},{"key":"10.1016\/j.ejmech.2018.11.032_bib34","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","article-title":"Recent advances of imidazole-containing derivatives as anti-tubercular activity","volume":"150","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib35","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.bmcl.2011.12.119","article-title":"Camphorsulfonic acid catalysed facile tandem double Friedlander annulation protocol for the synthesis of phenoxy linked bisquinoline derivatives and discovery of antitubercular agents","volume":"22","author":"Paul","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.11.032_bib37","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/AAC.48.4.1281-1288.2004","article-title":"Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity","volume":"48","author":"Aubry","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2018.11.032_bib38","series-title":"Guidelines for the Management of Drug-resistant Tuberculosis WHO\/TB\/96-210 (Rev.1)","author":"Crofton","year":"1997"},{"key":"10.1016\/j.ejmech.2018.11.032_bib39","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/jhet.3241","article-title":"Quinoline derivatives with potential activity against multidrug-resistant tuberculosis","volume":"55","author":"Liu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib40","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/jhet.3189","article-title":"Isatin derivatives with potential antitubercular activities","volume":"55","author":"Jiang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib42","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2323\/jgam.52.195","article-title":"Evaluation of antimycobacterial and DNA gyrase inhibition of fluoroquinolone derivatives","volume":"52","author":"Sriram","year":"2006","journal-title":"J.\u00a0Gen. Appl. Microbiol."},{"key":"10.1016\/j.ejmech.2018.11.032_bib43","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1016\/j.bmc.2005.05.063","article-title":"Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives","volume":"13","author":"Sriram","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib44","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.bmcl.2006.02.065","article-title":"Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase","volume":"16","author":"Sriram","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib45","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.ejmech.2010.04.027","article-title":"Synthesis and in\u00a0vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives","volume":"45","author":"Feng","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib46","first-page":"37","article-title":"Synthesis and in\u00a0vitro antimycobacterial activity of gatifloxacin ethylene isatin derivatives","volume":"36","author":"Wan","year":"2011","journal-title":"Chin. J. Antibiot."},{"key":"10.1016\/j.ejmech.2018.11.032_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ejmech.2010.11.023","article-title":"Synthesis and in\u00a0vitro antimycobacterial activity of 8-OCH3 ciprofloxacin methylene and ethylene isatin derivatives","volume":"46","author":"Feng","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib48","first-page":"61","article-title":"Synthesis and in\u00a0vitro antimycobacterial activity of moxifloxacin methylene and ethylene isatin derivatives","volume":"28","author":"Feng","year":"2012","journal-title":"Chem. Res. Chin. Univ."},{"key":"10.1016\/j.ejmech.2018.11.032_bib49","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/jhet.3157","article-title":"Design, synthesis and in\u00a0vitro antitubercular evaluation of isatinciprofloxacin hybrids with hydrogen bonding capacity","volume":"55","author":"Fan","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib50","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jhet.3227","article-title":"Design, synthesis, and in\u00a0vitro anti-mycobacterial activities of propylene-tethered gatifloxacin-isatin hybrids","volume":"55","author":"Wang","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jhet.3023","article-title":"Design, synthesis and in\u00a0vitro antimycobacterial activities of isatin-1,2,3-triazole-moxif loxacin hybrids","volume":"55","author":"Hu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib52","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmcl.2017.07.023","article-title":"Design, synthesis and in\u00a0vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib53","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: design, synthesis and in\u00a0vitroanti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib54","first-page":"3735","article-title":"1H-1,2,3-triazole-tethered 8-OMe ciprofloxacin and isatin hybrids: design, synthesis and in\u00a0vitro anti-mycobacterial activities","volume":"57","author":"Hu","year":"2017","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib55","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jhet.3032","article-title":"Design, synthesis and in\u00a0vitro anti-mycobacterial activity of propylene-1H-1,2,3-triazole-4-methylene-tethered isatin-moxifloxacin hybrids","volume":"55","author":"Hu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib56","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","article-title":"Synthesis and in\u00a0vitro evaluation of novel substituted isatinpropylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities","volume":"143","author":"Yan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jhet.3004","article-title":"Design, synthesis, and in\u00a0vitro anti-mycobacterial evaluation of propylene-1H-1,2,3-triazole-4-methylene-tethered (Thio)semicarbazone-isatin-moxifloxacin hybrids","volume":"55","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib58","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/emi.2016.12","volume":"5","author":"Ruan","year":"2016","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2018.11.032_bib59","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jhet.3112","article-title":"Coumarin-triazole hybrids and their biological activities","volume":"55","author":"Fan","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib60","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib61","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.14233\/ajchem.2017.20401","article-title":"Synthesis and in\u00a0vitro antimycobacterial activity of ciprofloxacin acetyl isatin derivatives","volume":"29","author":"Xu","year":"2017","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib62","article-title":"Gatifloxacin-isatin hybrids and their antimycobacterial activities","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib63","article-title":"Design, synthesis and antimycobacterial activities of diethylene glycol tethered moxifloxacin-isatin hybrids","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib64","article-title":"Ciprofloxacin-isatin hybrids and their antimycobacterial activities","author":"Xu","year":"2018","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib65","first-page":"113","article-title":"Anti-tubercular activity of isatin derivatives","volume":"1","author":"Aboul-Fadl","year":"2010","journal-title":"Int. J. Res. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2018.11.032_bib66","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000048533","article-title":"Antituberculous activity of norfloxacin Mannich bases with isatin derivatives","volume":"47","author":"Pandeya","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ejmech.2018.11.032_bib67","first-page":"327","article-title":"Novel Schiff bases of indoline-2,3-dione and nalidixic acid hydrazide: synthesis, in\u00a0vitro antimycobacterial and in silico mycobacterium tuberculosis (MTB) DNA gyrase inhibitory activity","volume":"7","author":"Aboul-Fadl","year":"2012","journal-title":"Dig. J. Nanomater. Bios."},{"key":"10.1016\/j.ejmech.2018.11.032_bib68","first-page":"217","article-title":"Schiff bases of indoline-2,3-dione (isatin) derivatives as efficient agents against resistant strains of Mycobacterium tuberculosis","volume":"7","author":"Aboul-Fadl","year":"2015","journal-title":"Der Pharma Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib69","doi-asserted-by":"crossref","first-page":"7864","DOI":"10.3390\/molecules16097864","article-title":"Schiff bases of indoline-2,3-dione: potential novel inhibitors of Mycobacterium tuberculosis (Mtb) DNA gyrase","volume":"16","author":"Aboul-Fadl","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.11.032_bib70","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.ejmech.2010.07.020","article-title":"Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building","volume":"45","author":"Aboul-Fadl","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib71","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent progress in the development of HIV-1 protease inhibitors for the treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib72","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/acs.jmedchem.5b00825","article-title":"A\u00a0journey around the medicinal chemistry of hepatitis C virus inhibitors targeting NS4B: from target to preclinical drug candidates","volume":"59","author":"Cannalire","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib73","first-page":"S63","article-title":"Isatin derivatives and their anti-HIV\/AIDS activities","volume":"38","author":"Xu","year":"2017","journal-title":"World Notes on Antibiotics"},{"key":"10.1016\/j.ejmech.2018.11.032_bib74","first-page":"27","article-title":"Biological activities of isatin and its derivatives","volume":"55","author":"Pandeya","year":"2005","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ejmech.2018.11.032_bib75","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1016\/j.bmc.2015.03.037","article-title":"Anti-HIV diarypyrimidine-quinolone hybrids and their mode of action","volume":"23","author":"Mao","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib76","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2174\/0929867033457142","article-title":"Towards the design and development of agents with broad spectrum chemotherapeutic properties for the effective treatment of HIV\/AIDS","volume":"10","author":"Sriram","year":"2003","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib77","series-title":"Summary of the Global HIV Epidemic","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.ejmech.2018.11.032_bib78","first-page":"565","article-title":"Aminopyrimidinimino isatin analogues: design of novel nonnucleoside HIV-1 reverse transcriptase inhibitors with broad spectrum chemotherapeutic properties","volume":"8","author":"Sriram","year":"2005","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2018.11.032_bib79","first-page":"274","article-title":"Synthesis, anti-HIV and antitubercular activities of isatin derivatives","volume":"61","author":"Sriram","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2018.11.032_bib80","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ejmech.2005.07.006","article-title":"Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs","volume":"40","author":"Sriram","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib81","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1016\/j.bmcl.2005.07.046","article-title":"Synthesis and evaluation of anti-HIV activity of isatin \u03b2-thiosemicarbazone derivatives","volume":"15","author":"Bal","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.11.032_bib82","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejmech.2010.10.020","article-title":"Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection","volume":"46","author":"Banerjee","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib83","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrc2914","article-title":"Cancer: an old disease, a new disease or something in between?","volume":"10","author":"David","year":"2010","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2018.11.032_bib84","first-page":"4273","article-title":"Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor","volume":"19","author":"Zink","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2018.11.032_bib85","unstructured":"World Health Organization. reportWorld Cancer Report 2014. Geneva."},{"key":"10.1016\/j.ejmech.2018.11.032_bib86","unstructured":"World Health Organization. Cancer control: knowledge into action. http:\/\/www.who.int\/cancer\/modules\/en\/."},{"key":"10.1016\/j.ejmech.2018.11.032_bib87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Tumor J. Clin."},{"key":"10.1016\/j.ejmech.2018.11.032_bib88","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1021\/cr900208x","article-title":"Introduction to cancer chemotherapeutics","volume":"109","author":"Shewach","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.032_bib89","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.052698099","article-title":"Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands","volume":"99","author":"Riou","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2018.11.032_bib90","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejmech.2017.12.043","article-title":"Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds","volume":"144","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib91","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1021\/jm2006047","article-title":"Synthesis and structure-activity evaluation of isatin-\u03b2-thiosemicarbazones with improved selective activity toward multidrug-resistant cells expressing P-glycoprotein","volume":"54","author":"Hall","year":"2011","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib92","doi-asserted-by":"crossref","first-page":"10250","DOI":"10.1002\/slct.201802185","article-title":"Synthesis and in\u00a0vitro anti-tumor, anti-mycobacterial and anti-HIV activities of diethylene-glycol-tethered bis-isatin derivatives","volume":"3","author":"Li","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2018.11.032_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.biopha.2005.06.006","article-title":"Synthesis and in-vitro cytotoxicity evaluation of Gatifloxacin Mannich bases","volume":"59","author":"Yogeeswari","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2018.11.032_bib94","first-page":"161","article-title":"Synthesis of ciprofloxacin-isatin conjugates as potential cytotoxic agents","volume":"26","author":"Emami","year":"2016","journal-title":"J.\u00a0Mazandaran Univ. Med. Sci."},{"key":"10.1016\/j.ejmech.2018.11.032_bib95","first-page":"570","article-title":"Synthesis, Antimicrobial and anticancer studies of isatin derivatives of Sparfloxacin","volume":"3","author":"Talath","year":"2013","journal-title":"Am. J. PharmTech Res."},{"key":"10.1016\/j.ejmech.2018.11.032_bib96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial Topoisomerase inhibitors: quinolone and pyridine anti-bacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.032_bib97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1021\/cr100063u","article-title":"4-Quinolones: smart phones of the microbial world","volume":"111","author":"Huse","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.11.032_bib98","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/17460441.2017.1319357","article-title":"An overview of quinoline as a privileged scaffold in cancer drug discovery","volume":"12","author":"Musiol","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.11.032_bib99","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejmech.2014.03.018","article-title":"Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids","volume":"77","author":"Nepali","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2016.09.023","article-title":"Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities","volume":"125","author":"Akhtar","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib101","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2017.07.033","article-title":"Recent advances (2015-2016) in anticancer hybrids","volume":"142","author":"Kerru","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.11.032_bib102","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrid molecules: the privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418309917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:39Z","timestamp":1759326519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418309917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":102,"alternative-id":["S0223523418309917"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.032","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone-isatin hybrids and their biological activities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}